Unsatisfied Reporting Quality of Clinical Trials Evaluating Immune Checkpoint Inhibitor Therapy in Cancer

BACKGROUND: More and more immune-oncology trials have been conducted for treating various cancers, yet it is unclear what the reporting quality of immune-oncology trials is,and characteristics associated with higher reporting quality. OBJECTIVE: This study aims to evaluate the reporting quality of i...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chen, Zhou, Yixin, Zhang, Xuanye, Wang, Yuhong, He, Li-na, Lin, Zuan, Chen, Tao, Jiang, Yongluo, Hong, Shaodong, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524036/
https://www.ncbi.nlm.nih.gov/pubmed/34675926
http://dx.doi.org/10.3389/fimmu.2021.736943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524036/
https://www.ncbi.nlm.nih.gov/pubmed/34675926
http://dx.doi.org/10.3389/fimmu.2021.736943

Ejemplares similares